Henrotin, Yves <br/><br/>
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.  [electronic resource] 

 -  BMC complementary and alternative medicine  May 2014 
 - 159 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1472-6882 
<br/><br/><label>Standard No.: </label>10.1186/1472-6882-14-159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Inflammatory Agents--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Collagen--blood<br/>Collagen Type I--urine<br/>Curcumin--therapeutic use<br/>Extracellular Matrix Proteins--blood<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteoarthritis--drug therapy<br/>Osteoarthritis, Knee--drug therapy<br/>Pain Measurement<br/>Peptides--urine<br/>Peroxidase--blood<br/>Phytotherapy<br/>Treatment Outcome